Pharmedic Pharmaceutical Medicinal Joint Stock Company - Laporan Laba Rugi (TTM)

Pharmedic Pharmaceutical Medicinal Joint Stock Company
VN ˙ HNX
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Pharmedic Pharmaceutical Medicinal Joint Stock Company menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2021
01-01
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 457,843 460,764 448,821 470,852 404,788 414,232 414,456 408,974 484,469 472,274 458,682 455,205 479,794 485,186 483,237 516,738 493,367 498,185 522,630 517,711
Change (%) 0.64 -2.59 4.91 -14.03 2.33 0.05 -1.32 18.46 -2.52 -2.88 -0.76 5.40 1.12 -0.40 6.93 -4.52 0.98 4.91 -0.94
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 279,043 284,276 278,658 295,495 262,657 266,740 262,218 254,608 292,686 285,918 282,036 285,144 310,797 315,134 314,023 336,395 311,612 310,972 316,534 305,168
Change (%) 1.88 -1.98 6.04 -11.11 1.55 -1.70 -2.90 14.96 -2.31 -1.36 1.10 9.00 1.40 -0.35 7.12 -7.37 -0.21 1.79 -3.59
% of Revenue 60.95 61.70 62.09 62.76 64.89 64.39 63.27 62.26 60.41 60.54 61.49 62.64 64.78 64.95 64.98 65.10 63.16 62.42 60.57 58.95
Gross Operating Profit 178,800 176,488 170,163 175,357 142,130 147,492 152,238 154,366 191,783 186,356 176,645 170,061 168,997 170,053 169,214 180,343 181,754 187,213 206,097 212,542
Change (%) -1.29 -3.58 3.05 -18.95 3.77 3.22 1.40 24.24 -2.83 -5.21 -3.73 -0.63 0.62 -0.49 6.58 0.78 3.00 10.09 3.13
% of Revenue 39.05 38.30 37.91 37.24 35.11 35.61 36.73 37.74 39.59 39.46 38.51 37.36 35.22 35.05 35.02 34.90 36.84 37.58 39.43 41.05
SG&A 92,709 90,801 87,837 89,343 73,717 74,912 77,439 79,213 96,812 95,588 91,178 87,292 85,205 85,645 85,717 89,257 89,329 96,729 106,195 112,856
Change (%) -2.06 -3.26 1.72 -17.49 1.62 3.37 2.29 22.22 -1.26 -4.61 -4.26 -2.39 0.52 0.08 4.13 0.08 8.28 9.79 6.27
% of Revenue 20.25 19.71 19.57 18.97 18.21 18.08 18.68 19.37 19.98 20.24 19.88 19.18 17.76 17.65 17.74 17.27 18.11 19.42 20.32 21.80
R&D
Change (%)
% of Revenue
OpEx 371,752 375,077 366,494 384,839 336,374 341,652 339,656 333,821 389,498 381,506 373,214 372,437 396,002 400,779 399,765 425,652 400,941 407,701 422,711 418,025
Change (%) 0.89 -2.29 5.01 -12.59 1.57 -0.58 -1.72 16.68 -2.05 -2.17 -0.21 6.33 1.21 -0.25 6.48 -5.81 1.69 3.68 -1.11
% of Revenue 81.20 81.40 81.66 81.73 83.10 82.48 81.95 81.62 80.40 80.78 81.37 81.82 82.54 82.60 82.73 82.37 81.27 81.84 80.88 80.74
Operating Income 86,092 85,687 82,326 86,013 68,414 72,580 74,800 75,153 94,971 90,768 85,467 82,768 83,791 84,408 83,472 91,086 92,425 90,484 99,920 99,686
Change (%) -0.47 -3.92 4.48 -20.46 6.09 3.06 0.47 26.37 -4.43 -5.84 -3.16 1.24 0.74 -1.11 9.12 1.47 -2.10 10.43 -0.23
% of Revenue 18.80 18.60 18.34 18.27 16.90 17.52 18.05 18.38 19.60 19.22 18.63 18.18 17.46 17.40 17.27 17.63 18.73 18.16 19.12 19.26
Interest Expense -14 -43
Change (%)
% of Revenue -0.00 -0.01
Net Income 75,194 74,618 71,329 75,019 59,644 64,760 65,911 67,529 84,866 83,416 80,097 81,481 81,865 83,564 83,105 84,344 85,071 80,133 88,132 86,315
Change (%) -0.77 -4.41 5.17 -20.49 8.58 1.78 2.46 25.67 -1.71 -3.98 1.73 0.47 2.08 -0.55 1.49 0.86 -5.80 9.98 -2.06
% of Revenue 16.42 16.19 15.89 15.93 14.73 15.63 15.90 16.51 17.52 17.66 17.46 17.90 17.06 17.22 17.20 16.32 17.24 16.09 16.86 16.67

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista